Tuesday, April 17, 2012

Off-label prescribing of medications is common, Canadian study suggests

ScienceDaily (Apr. 16, 2012) ? A study evaluating off-label prescribing of medications in a primary care network in Canada suggests the practice is common, although it varies by medication, patient and physician characteristics, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The report is part of the journal's Health Care Reform series.

Off-label prescribing is the practice of using prescription medications for indications that have not received regulatory approval. The practice is suspected to be a factor of preventable adverse medication events, the authors write in their study background.

Tewodros Eguale, M.D., M.Sc., of McGill University, Montreal, Canada, and colleagues used the Medical Office of the XXI Century primary care electronic health record network research program in Quebec to examine off-label use. A total of 113 primary care physicians wrote 253,347 electronic prescriptions for 50,823 patients from January 2005 through December 2009.

Overall, 11 percent of medications were prescribed for an off-label indication and 79 percent of off-label use lacked strong scientific evidence, the results indicate. The authors note the magnitude of off-label use was less than in a U.S. study.

In the present study, the highest proportion of off-label prescribing involved central nervous system medications (26.3 percent), anti-infective agents (17.1 percent) and ear-nose-throat medications (15.2 percent), according to the study results.

The results indicate that medications with three or four approved indications were associated with lower off-label use compared to those with one or two approved indications. Medications approved after 1995 also were associated with lower off-label use than those approved before 1981. Physicians with high scores on evidence-based practice were less likely to prescribe off-label.

"In conclusion, our findings indicate that off-label prescribing is common in primary care and varies by drug class, the number of approved indications for the drug, the age of the drug, patients' sex and physicians' attitude toward evidence-based medicine," the authors conclude. "Electronic health records can be used to document treatment indication at the time of prescribing and may pave the way for enhanced postmarketing evaluation of drugs if linked to treatment outcomes."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by JAMA and Archives Journals.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

  1. Tewodros Eguale, David L. Buckeridge, Nancy E. Winslade, Andrea Benedetti, James A. Hanley, Robyn Tamblyn. Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary Care. Arch Intern Med, April 16, 2012 DOI: 10.1001/archinternmed.2012.340

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

fred davis fred davis fracking fracking drosselmeyer drosselmeyer local time

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.